1. Home
  2. ALMS vs VALU Comparison

ALMS vs VALU Comparison

Compare ALMS & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • VALU
  • Stock Information
  • Founded
  • ALMS 2021
  • VALU 1931
  • Country
  • ALMS United States
  • VALU United States
  • Employees
  • ALMS N/A
  • VALU N/A
  • Industry
  • ALMS
  • VALU Investment Managers
  • Sector
  • ALMS
  • VALU Finance
  • Exchange
  • ALMS NYSE
  • VALU Nasdaq
  • Market Cap
  • ALMS 402.6M
  • VALU 384.1M
  • IPO Year
  • ALMS 2024
  • VALU N/A
  • Fundamental
  • Price
  • ALMS $3.29
  • VALU $38.15
  • Analyst Decision
  • ALMS Strong Buy
  • VALU
  • Analyst Count
  • ALMS 7
  • VALU 0
  • Target Price
  • ALMS $26.83
  • VALU N/A
  • AVG Volume (30 Days)
  • ALMS 1.1M
  • VALU 2.6K
  • Earning Date
  • ALMS 05-14-2025
  • VALU 07-25-2025
  • Dividend Yield
  • ALMS N/A
  • VALU 3.36%
  • EPS Growth
  • ALMS N/A
  • VALU 17.96
  • EPS
  • ALMS N/A
  • VALU 2.28
  • Revenue
  • ALMS $17,389,000.00
  • VALU $35,695,000.00
  • Revenue This Year
  • ALMS N/A
  • VALU N/A
  • Revenue Next Year
  • ALMS N/A
  • VALU N/A
  • P/E Ratio
  • ALMS N/A
  • VALU $17.16
  • Revenue Growth
  • ALMS N/A
  • VALU N/A
  • 52 Week Low
  • ALMS $3.18
  • VALU $32.94
  • 52 Week High
  • ALMS $13.53
  • VALU $57.68
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • VALU 43.18
  • Support Level
  • ALMS N/A
  • VALU $37.95
  • Resistance Level
  • ALMS N/A
  • VALU $40.00
  • Average True Range (ATR)
  • ALMS 0.00
  • VALU 0.68
  • MACD
  • ALMS 0.00
  • VALU -0.13
  • Stochastic Oscillator
  • ALMS 0.00
  • VALU 8.23

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About VALU Value Line Inc.

Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.

Share on Social Networks: